Codrin Lungu

Codrin Lungu


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2014 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
AYAndrew I. Yang
Andrew I. Yang
NVNora Vanegas
Nora Vanegas
CLCodrin Lungu
Codrin Lungu
KZKareem A. Zaghloul
Kareem A. Zaghloul
Beta frequency (13–30 Hz) oscillatory activity in the subthalamic nucleus (STN) of Parkinson9s disease (PD) has been shown to influence the temporal dynamics of high-frequency oscillations (HFOs; 200–500 Hz) and single neurons, potentially compromising the functional flexibility of the motor circuit. We examined these interactions by simultaneously recording both local field potential and single-unit activity from the basal ganglia of 15 patients with PD during deep brain stimulation (DBS) surgery of the bilateral STN. Phase-amplitude coupling (PAC) in the STN was specific to beta phase and HFO amplitude, and this coupling was strongest at the dorsal STN border. We found higher beta-HFO PAC near DBS lead contacts that were clinically effective compared with the remaining non-effective contacts, indicating that PAC may be predictive of response to STN DBS. Neuronal spiking was locked to the phase of 8–30 Hz oscillations, and the spatial topography of spike-phase locking (SPL) was similar to that of PAC. Comparisons of PAC and SPL showed a lack of spatiotemporal correlations. Beta-coupled HFOs and field-locked neurons had different preferred phase angles and did not co-occur within the same cycle of the modulating oscillation. Our findings provide additional support that beta-HFO PAC may be central to the pathophysiology of PD and suggest that field-locked neurons alone are not sufficient for the emergence of beta-coupled HFOs.

26 February 2016 in Brain
Verified
Journal Article
Open access
PDF file
NVNora Vanegas-Arroyave
Nora Vanegas-Arroyave
PLPeter M. Lauro
Peter M. Lauro
LHLing Huang
Ling Huang
MHMark Hallett
Mark Hallett
SHSilvina G. Horovitz
Silvina G. Horovitz
CLCodrin Lungu
Codrin Lungu
Deep brain stimulation therapy is an effective symptomatic treatment for Parkinson’s disease, yet the precise mechanisms responsible for its therapeutic effects remain unclear. Although the targets of deep brain stimulation are grey matter structures, axonal modulation is known to play an important role in deep brain stimulation’s therapeutic mechanism. Several white matter structures in proximity to the subthalamic nucleus have been implicated in the clinical benefits of deep brain stimulation for Parkinson’s disease. We assessed the connectivity patterns that characterize clinically beneficial electrodes in Parkinson’s disease patients, after deep brain stimulation of the subthalamic nucleus. We evaluated 22 patients with Parkinson’s disease (11 females, age 57 ± 9.1 years, disease duration 13.3 ± 6.3 years) who received bilateral deep brain stimulation of the subthalamic nucleus at the National Institutes of Health. During an initial electrode screening session, one month after deep brain stimulation implantation, the clinical benefits of each contact were determined. The electrode was localized by coregistering preoperative magnetic resonance imaging and postoperative computer tomography images and the volume of tissue activated was estimated from stimulation voltage and impedance. Brain connectivity for the volume of tissue activated of deep brain stimulation contacts was assessed using probabilistic tractography with diffusion-tensor data. Areas most frequently connected to clinically effective contacts included the thalamus, substantia nigra, brainstem and superior frontal gyrus. A series of discriminant analyses demonstrated that the strength of connectivity to the superior frontal gyrus and the thalamus were positively associated with clinical effectiveness. The connectivity patterns observed in our study suggest that the modulation of white matter tracts directed to the superior frontal gyrus and the thalamus is associated with favourable clinical outcomes and may contribute to the therapeutic effects of deep brain stimulation. Our method can be further developed to reliably identify effective deep brain stimulation contacts and aid in the programming process.

1 June 2018 in Toxicon
Verified
Journal Article
Closed access
HJHyder Jinnah
Hyder Jinnah
CCCynthia L. Comella
Cynthia L. Comella
JPJoel S Perlmutter
Joel S Perlmutter
CLCodrin Lungu
Codrin Lungu
MHMark Hallett
Mark Hallett

30 September 2018 in Journal of Movement Disorders
Verified
Journal Article
Open access
PDF file
ASAnshul Srivastava
Anshul Srivastava
OAOmar F. Ahmad
Omar F. Ahmad
CPChristopher Pham Pacia
Christopher Pham Pacia
MHMark Hallett
Mark Hallett
CLCodrin Lungu
Codrin Lungu
Human locomotion involves a complex interplay among multiple brain regions and depends on constant feedback from the visual system. We summarize here the current understanding of the relationship among fixations, saccades, and gait as observed in studies sampling eye movements during locomotion, through a review of the literature and a synthesis of the relevant knowledge on the topic. A significant overlap in locomotor and saccadic neural circuitry exists that may support this relationship. Several animal studies have identified potential integration nodes between these overlapping circuitries. Behavioral studies that explored the relationship of saccadic and gait-related impairments in normal conditions and in various disease states are also discussed. Eye movements and locomotion share many underlying neural circuits, and further studies can leverage this interplay for diagnostic and therapeutic purposes.

25 February 2020 in Neurology
Verified
Journal Article
Closed access
PDF file
CLCodrin Lungu
Codrin Lungu
LOLaurie Ozelius
Laurie Ozelius
DSDavid Standaert
David Standaert
MHMark Hallett
Mark Hallett
BSBeth-Anne Sieber
Beth-Anne Sieber
JVJerrold Vitek
Jerrold Vitek
Objective Dystonia is a complex movement disorder. Research progress has been difficult, particularly in developing widely effective therapies. This is a review of the current state of knowledge, research gaps, and proposed research priorities. Methods The NIH convened leaders in the field for a 2-day workshop. The participants addressed the natural history of the disease, the underlying etiology, the pathophysiology, relevant research technologies, research resources, and therapeutic approaches and attempted to prioritize dystonia research recommendations. Results The heterogeneity of dystonia poses challenges to research and therapy development. Much can be learned from specific genetic subtypes, and the disorder can be conceptualized along clinical, etiology, and pathophysiology axes. Advances in research technology and pooled resources can accelerate progress. Although etiologically based therapies would be optimal, a focus on circuit abnormalities can provide a convergent common target for symptomatic therapies across dystonia subtypes. The discussions have been integrated into a comprehensive review of all aspects of dystonia. Conclusion Overall research priorities include the generation and integration of high-quality phenotypic and genotypic data, reproducing key features in cellular and animal models, both of basic cellular mechanisms and phenotypes, leveraging new research technologies, and targeting circuit-level dysfunction with therapeutic interventions. Collaboration is necessary both for collection of large data sets and integration of different research methods.

12 November 2012 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
CLCodrin Lungu
Codrin Lungu
ECE. Considine
E. Considine
SZS. Zahir
S. Zahir
BPB. Ponsati
B. Ponsati
SAS. Arrastia
S. Arrastia
MHM. Hallett
M. Hallett